<https://www.empr.com/home/news/drugs-in-the-pipeline/phase-3-study-of-lixisenatide-for-type-2-diabetes/#breadcrumb>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<https://www.empr.com/home/news/drugs-in-the-pipeline/phase-3-study-of-lixisenatide-for-type-2-diabetes/>